Compounds and methods for treating leukemia
AssigneeIndiana University Research and Technology Corporation
InventorsMark R. Kelley, Melissa L. Fishel, Angelo A. Cardoso
Life of this patent
Estimating the term…
Abstract
Compounds, and methods and uses of compounds, and pharmaceutical compositions thereof, are described herein for treating leukemia. In particular, compounds, and methods and uses of compounds, and pharmaceutical compositions thereof, are described herein for treating acute lymphoblastic leukemia (ALL) in its various forms.
Claims5
A method for treating leukemia selected from the group consisting of childhood acute lymphoblastic leukemia (ALL), infant ALL, T-cell ALL (T-ALL), relapsed ALL, refractory ALL, and glucocorticoid-resistant ALL in a patient, the method comprising the step of administering an effective amount of at least one compound selected from the group consisting of
- -(5-(2,3-dimethoxy-6-methyl 1,4-benzoquinoyl)]-2-nonyl-2-propenoic acid (E3330)) or a pharmaceutically acceptable salt or solvate thereof.
Dependencies are inferred from the claim text.